These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3034547)

  • 1. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of ras and myc proto-oncogenes in human breast carcinoma and neuroblastoma].
    Kniazev PG; Schafer R; Willecke K; Pluzhnikova GF; Serova OM
    Mol Biol (Mosk); 1986; 20(5):1236-43. PubMed ID: 3022123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
    Nikiforova IF
    Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative detection of amplification of proto-oncogenes in breast cancer.
    Chen Y; Dong J; Lu Y; McGee JO
    Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical and molecular biological aspects of stomach cancer development in human and animal].
    Khanson KP; Kalinovskiĭ VP; Novikov LB; Fedorov SN
    Vopr Med Khim; 1991; 37(6):84-8. PubMed ID: 1812623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
    Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
    Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of proto-oncogene amplification in human malignant diseases.
    Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
    Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
    Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
    Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast.
    Mariani-Costantini R; Escot C; Theillet C; Gentile A; Merlo G; Lidereau R; Callahan R
    Cancer Res; 1988 Jan; 48(1):199-205. PubMed ID: 2825967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
    Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
    Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
    Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
    Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc oncogene alterations in human thyroid carcinomas.
    del Senno L; Gambari R; degli Uberti E; Barbieri R; Bernardi F; Buzzoni D; Marchetti G; Pansini G; Perrotta C; Conconi F
    Cancer Detect Prev; 1987; 10(3-4):159-66. PubMed ID: 2436779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.